Skip to Content

S 712 (Topiramate 200 mg)

Pill imprint S 712 has been identified as Topiramate 200 mg.

Topiramate is used in the treatment of obesity; migraine prevention; bipolar disorder; fibromyalgia; diabetic peripheral neuropathy (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Topiramate 200 mg S 712
Topiramate 200 mg S 712 Front
Topiramate 200 mg S 712 Back
Topiramate 200 mg S 712
S 712
200 mg
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Sun Pharmaceuticals
National Drug Code (NDC):
Inactive Ingredients:
lactose anhydrous
microcrystalline cellulose
corn starch
sodium starch glycolate type A potato
magnesium stearate
polyvinyl alcohol
titanium dioxide
polyethylene glycol
magnesium silicate
ferric oxide red
soya lecithin
ferrosoferric oxide

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
47335-0712 Sun Pharmaceutical Industries Inc.
21695-0349 Rebel Distributors Corp (repackager)
68258-3002 Dispensing Solutions Inc. (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.